DK0699439T3 - Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer - Google Patents
Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorerInfo
- Publication number
- DK0699439T3 DK0699439T3 DK95305594T DK95305594T DK0699439T3 DK 0699439 T3 DK0699439 T3 DK 0699439T3 DK 95305594 T DK95305594 T DK 95305594T DK 95305594 T DK95305594 T DK 95305594T DK 0699439 T3 DK0699439 T3 DK 0699439T3
- Authority
- DK
- Denmark
- Prior art keywords
- acyl
- diseases caused
- sebaceous gland
- cholesterolacyltransferase
- coa
- Prior art date
Links
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 title abstract 4
- 108010054082 Sterol O-acyltransferase Proteins 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 210000001732 sebaceous gland Anatomy 0.000 title abstract 3
- 241001465754 Metazoa Species 0.000 abstract 3
- 208000015390 Sebaceous gland disease Diseases 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 230000028327 secretion Effects 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/298,735 US6133326A (en) | 1994-08-31 | 1994-08-31 | Compositions and methods for decreasing sebum production |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0699439T3 true DK0699439T3 (da) | 1999-12-27 |
Family
ID=23151816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95305594T DK0699439T3 (da) | 1994-08-31 | 1995-08-10 | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer |
Country Status (9)
Country | Link |
---|---|
US (2) | US6133326A (da) |
EP (1) | EP0699439B1 (da) |
JP (2) | JP3266473B2 (da) |
AT (1) | ATE185271T1 (da) |
CA (1) | CA2157142C (da) |
DE (1) | DE69512589T2 (da) |
DK (1) | DK0699439T3 (da) |
ES (1) | ES2136252T3 (da) |
GR (1) | GR3031917T3 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080408A (en) * | 1994-08-22 | 2000-06-27 | Connaught Laboratories Limited | Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles |
CN1195550C (zh) * | 1998-12-28 | 2005-04-06 | 大正制药株式会社 | 外用剂 |
US20030077301A1 (en) * | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
IL150865A0 (en) * | 2000-02-02 | 2003-02-12 | Warner Lambert Co | Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders |
IL159156A0 (en) * | 2001-06-22 | 2004-06-01 | Millard Marsden Mershon | A gel forming composition containing a polyacrylic acid |
EP1281399A3 (en) * | 2001-08-01 | 2004-02-11 | Warner-Lambert Company | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
CA2478237C (en) * | 2002-03-12 | 2009-05-12 | Michael Graeber | Use of adapalene for the treatment of dermatological disorders |
JP2009102358A (ja) * | 2003-07-29 | 2009-05-14 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
JP2005060386A (ja) * | 2003-07-29 | 2005-03-10 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
KR100786436B1 (ko) | 2003-10-09 | 2007-12-17 | 워너-램버트 캄파니 엘엘씨 | 피지 생성을 감소시키기 위한 말론아마이드 유도체를포함하는 약학 조성물 |
KR100906288B1 (ko) * | 2005-02-24 | 2009-07-06 | 워너-램버트 캄파니 엘엘씨 | 결정질 acat 억제제 |
FR2918890A1 (fr) * | 2007-07-19 | 2009-01-23 | Galderma Res & Dev | Utilisation du pactimibe pour la preparation d'un medicament destine a prevenir ou a traiter une maladie due a un dysfonctionnement des glandes sebacees chez l'homme ou l'animal |
FR2918889B1 (fr) * | 2007-07-19 | 2009-10-23 | Galderma Res & Dev | Utilisation de l'eflucimibe pour la preparation d'un medicament destine a prevenir ou a traiter une maladie due a un dysfonctionnement des glandes sebacees chez l'homme ou l'animal |
FR2920771B1 (fr) * | 2007-09-06 | 2009-10-30 | Galderma Res & Dev | Nouveaux derives de phenylurees, inhibiteurs de l'enzymes soat-1, compositions pharmaceutiques et cosmetiques les contenant |
FR2920769B1 (fr) | 2007-09-06 | 2009-10-30 | Galderma Res & Dev | Nouveaux derives de n-phenyl acetamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant |
CN101502541B (zh) * | 2008-02-04 | 2011-12-28 | 成都地奥九泓制药厂 | 安息香属植物及其提取物的用途 |
FR2946342B1 (fr) | 2009-06-05 | 2011-06-24 | Galderma Res & Dev | Nouveaux derives de dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
FR2946340B1 (fr) | 2009-06-05 | 2011-06-24 | Galderma Res & Dev | Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
FR2946346B1 (fr) | 2009-06-05 | 2011-05-20 | Galderma Res & Dev | Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
FR2946345B1 (fr) | 2009-06-05 | 2011-05-20 | Galderma Res & Dev | Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
US11865113B2 (en) | 2016-06-06 | 2024-01-09 | Lipidio Pharmaceuticals Inc. | Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH) |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3729568A (en) | 1969-09-23 | 1973-04-24 | Johnson & Johnson | Acne treatment |
US4302456A (en) * | 1977-04-13 | 1981-11-24 | The Upjohn Company | Process for therapeutic treatment |
US4514385A (en) * | 1981-10-05 | 1985-04-30 | Alcon Laboratories, Inc. | Anti-acne compositions |
EP0170105B1 (en) | 1984-07-07 | 1990-10-17 | Koichi Prof. Dr. Shudo | Benzoic acid derivatives |
LU86258A1 (fr) | 1986-01-21 | 1987-09-03 | Rech Dermatologiques C I R D S | Composes benzamido aromatique,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
US4751026A (en) | 1986-03-24 | 1988-06-14 | Warner-Lambert Company | Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase |
US4722927A (en) | 1986-04-28 | 1988-02-02 | Warner-Lambert Company | Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase |
JPS6323848A (ja) | 1986-07-11 | 1988-02-01 | ワ−ナ−−ランバ−ト・コンパニ− | Ω−(置換フエニルオキシ)−アルカン酸のアリ−ル−およびアラルキルアミド |
US4743605A (en) | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase |
US4716175A (en) * | 1987-02-24 | 1987-12-29 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase |
IE61716B1 (en) | 1987-06-02 | 1994-11-30 | Warner Lambert Co | Antihyperlipidemic and antiatherosclerotic urea compounds |
US5015644A (en) | 1987-06-02 | 1991-05-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
DE3861988D1 (en) | 1987-07-02 | 1991-04-18 | Warner Lambert Co | N-((2,6-disubstituierte)-phenyl)-harnstoff und -carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase. |
US5116848A (en) | 1988-03-30 | 1992-05-26 | Warner-Lambert Company | N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
US5155127A (en) | 1989-02-09 | 1992-10-13 | Warner-Lambert Company | N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
US4994465A (en) * | 1989-02-17 | 1991-02-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds |
US5204093A (en) * | 1989-04-06 | 1993-04-20 | Victor Steven A | Shaving cream composition for the treatment of acne vulgaris and pseudofolliculitis barbae and method of producing and using same |
AU632809B2 (en) | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
AU629376B2 (en) | 1989-08-04 | 1992-10-01 | Mitsubishi Chemical Corporation | 1-phenylalkyl-3-phenylurea derivatives |
WO1991004027A1 (en) | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
TW205037B (da) | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd | |
JPH05310678A (ja) | 1990-01-22 | 1993-11-22 | Mitsubishi Kasei Corp | 1−フェニルアルキル−3−フェニル尿素誘導体 |
ATE175196T1 (de) * | 1992-01-23 | 1999-01-15 | Pfizer | 4-phenyl-3-(heteroarylureido)-1,2-dihydro-2- oxochinolin derivate, als antihypercholesterolemische und antiatherosklerotische mittel |
US6001860A (en) * | 1992-05-28 | 1999-12-14 | Pfizer Inc. | N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT) |
US5902805A (en) * | 1996-04-22 | 1999-05-11 | L'oreal | Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same |
US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
US5834480A (en) * | 1997-06-13 | 1998-11-10 | Elkhoury; George F. | Topical application of opioids for treatment of acne and sebaceous gland disorders |
US5994330A (en) * | 1998-11-09 | 1999-11-30 | El Khoury; Georges F. | Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions |
US9206485B2 (en) | 2011-08-19 | 2015-12-08 | J. Edwin Roy | Portable sugar mill |
US9303539B1 (en) | 2012-06-10 | 2016-04-05 | Ags I-Prop, Llc | Universal drain plug system and method |
US9210886B2 (en) | 2014-03-27 | 2015-12-15 | Monsanto Technology Llc | Plants and seeds of corn variety CV410274 |
-
1994
- 1994-08-31 US US08/298,735 patent/US6133326A/en not_active Expired - Fee Related
-
1995
- 1995-08-10 AT AT95305594T patent/ATE185271T1/de not_active IP Right Cessation
- 1995-08-10 DE DE69512589T patent/DE69512589T2/de not_active Expired - Lifetime
- 1995-08-10 DK DK95305594T patent/DK0699439T3/da active
- 1995-08-10 ES ES95305594T patent/ES2136252T3/es not_active Expired - Lifetime
- 1995-08-10 EP EP95305594A patent/EP0699439B1/en not_active Expired - Lifetime
- 1995-08-29 JP JP24229795A patent/JP3266473B2/ja not_active Expired - Lifetime
- 1995-08-29 CA CA002157142A patent/CA2157142C/en not_active Expired - Lifetime
-
1999
- 1999-11-19 GR GR990403007T patent/GR3031917T3/el unknown
-
2000
- 2000-03-27 US US09/536,480 patent/US6271268B1/en not_active Expired - Lifetime
-
2001
- 2001-08-09 JP JP2001241766A patent/JP2002053494A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2136252T3 (es) | 1999-11-16 |
US6271268B1 (en) | 2001-08-07 |
DE69512589T2 (de) | 2000-01-27 |
CA2157142C (en) | 1998-06-09 |
JP3266473B2 (ja) | 2002-03-18 |
ATE185271T1 (de) | 1999-10-15 |
JPH0899903A (ja) | 1996-04-16 |
CA2157142A1 (en) | 1996-03-01 |
GR3031917T3 (en) | 2000-03-31 |
DE69512589D1 (de) | 1999-11-11 |
US6133326A (en) | 2000-10-17 |
EP0699439A2 (en) | 1996-03-06 |
EP0699439B1 (en) | 1999-10-06 |
EP0699439A3 (en) | 1996-06-26 |
JP2002053494A (ja) | 2002-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
ATE409486T1 (de) | Behandlung hyperproliferativer erkrankungen | |
UY25322A1 (es) | Compuestos de tiourea y benzamida,composiciones y metodos para tratar y prevenir enfermedades inflamatorias y aterosclerosis | |
ATE303162T1 (de) | Natrium kanalblocker zusammensetzungen und deren verwendung | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
ES2295609T3 (es) | Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor. | |
DE69636342D1 (de) | Liponsäure in topischen mittel | |
DK0867178T3 (da) | Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser | |
PT99597B (pt) | Processo para a preparacao de derivados do acido hidroxamico que inibem a lipoxigenase | |
BR9809115A (pt) | Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt | |
NO20030724D0 (no) | Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser | |
LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
DK0694545T3 (da) | Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder | |
DE59608698D1 (de) | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure | |
EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
BR0110396A (pt) | Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia | |
CZ63295A3 (en) | 1 alpha-fluoro-25-hydroxy-16-en-23-in-cholecalciferol as such and for the use as a therapeutic active compound, its use for the preparation of a pharmaceutical preparation, process of its preparation and a pharmaceutical preparation based thereon | |
HUT77135A (hu) | Eljárás I típusú allergiás betegségek megelőzésére és kezelésére alkalmazható gyógyszerkészítmények előállítására | |
HUT70757A (en) | Pharmaceutical compositions for treating skin disorders | |
BR9710901A (pt) | M-todo para o tratamento da doen-a bipolar | |
DK1011672T3 (da) | Anvendelse af (E)-metanicotin derivater til frembringelse af analgetiske virkninger | |
GEP20032956B (en) | Miticide Composition | |
ATE334982T1 (de) | 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- | |
MX9605153A (es) | Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas. |